KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Equity Average: 2010-2014

Historic Equity Average for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2014 value amounting to $37.3 million.

  • Biocryst Pharmaceuticals' Equity Average fell 19.25% to $70.1 million in Q3 2015 from the same period last year, while for Sep 2015 it was $70.1 million, marking a year-over-year decrease of 19.25%. This contributed to the annual value of $37.3 million for FY2014, which is 4815.76% up from last year.
  • Per Biocryst Pharmaceuticals' latest filing, its Equity Average stood at $37.3 million for FY2014, which was up 4,815.76% from -$790,000 recorded in FY2013.
  • Biocryst Pharmaceuticals' 5-year Equity Average high stood at $75.9 million for FY2010, and its period low was -$790,000 during FY2013.
  • In the last 3 years, Biocryst Pharmaceuticals' Equity Average had a median value of $7.2 million in 2012 and averaged $14.5 million.
  • As far as peak fluctuations go, Biocryst Pharmaceuticals' Equity Average crashed by 111.01% in 2013, and later soared by 4,815.76% in 2014.
  • Biocryst Pharmaceuticals' Equity Average (Yearly) stood at $75.9 million in 2010, then crashed by 47.08% to $40.2 million in 2011, then slumped by 82.13% to $7.2 million in 2012, then plummeted by 111.01% to -$790,000 in 2013, then soared by 4,815.76% to $37.3 million in 2014.